Yahoo
XETRA - Delayed Quote EUR

RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE)

14.30 -0.20 (-1.38%)
As of 2:11:46 PM GMT+2. Market Open.
Chart Range Bar
Loading chart for RHK.DE
  • Previous Close 14.50
  • Open 14.50
  • Bid 14.20 x 15100
  • Ask 14.30 x 14500
  • Day's Range 14.20 - 14.50
  • 52 Week Range 11.50 - 15.70
  • Volume 551
  • Avg. Volume 5,267
  • Market Cap (intraday) 957.22M
  • Beta (5Y Monthly) -0.00
  • PE Ratio (TTM) 22.34
  • EPS (TTM) 0.64
  • Earnings Date Nov 5, 2026
  • Forward Dividend & Yield 0.20 (1.38%)
  • Ex-Dividend Date May 28, 2026
  • 1y Target Est 12.50

RHÖN-KLINIKUM Aktiengesellschaft, together with its subsidiaries, provides in-patient, semi-patient, and outpatient healthcare services in Germany. The company operates acute hospitals, medical care centers, and rehabilitation hospitals. RHÖN-KLINIKUM Aktiengesellschaft was founded in 1973 and is based in Bad Neustadt an der Saale, Germany.

www.rhoen-klinikum-ag.com

19,120

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Performance Overview

Trailing total returns as of 10/19/2026, which may include dividends or other distributions. Benchmark is DAX P (^GDAXI) .

YTD Return

RHK.DE
14.43%
DAX P (^GDAXI)
3.14%

1-Year Return

RHK.DE
24.21%
DAX P (^GDAXI)
5.99%

3-Year Return

RHK.DE
26.31%
DAX P (^GDAXI)
67.89%

5-Year Return

RHK.DE
4.59%
DAX P (^GDAXI)
62.79%

Earnings Trends

View More

Earnings Per Share

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q3 FY22
Revenue 356.06M
Earnings --
Profit Margin 0.00%

Q2

FY19

Q3

FY19

Q2

FY22

Q3

FY22

0
100M
200M
300M
0.0%
1.0%
2.0%
3.0%
4.0%
5.0%

Analyst Insights

View More

Analyst Price Targets

12.50 Low
12.50 Average
14.30 Current
12.50

Statistics

View More

Valuation Measures

Annual
As of 9/23/2026
  • Market Cap

    963.91M

  • Enterprise Value

    743.66M

  • Trailing P/E

    22.50

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    0.56

  • Price/Book (mrq)

    0.73

  • Enterprise Value/Revenue

    0.43

  • Enterprise Value/EBITDA

    6.04

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.08%

  • Return on Assets (ttm)

    1.85%

  • Return on Equity (ttm)

    3.28%

  • Revenue (ttm)

    2.03B

  • Net Income Avi to Common (ttm)

    42.09M

  • Diluted EPS (ttm)

    0.64

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    312.78M

  • Total Debt/Equity (mrq)

    8.96%

  • Levered Free Cash Flow (ttm)

    -63.14M

Compare

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: